… episodes in patients implanted with a cardioverter-defibrillator–results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P)

F Regoli, D Graf, B Schaer, F Duru, P Ammann… - BMC cardiovascular …, 2019 - Springer
… before a shock is delivered following the capacitor charge. … Antitachycardia pacing and
shocks restored sinus rhythm in … , categorization, and treatment of ventricular arrhythmias to limit …

Quality of life in patients with a subcutaneous vs. transvenous implantable cardioverter-defibrillator

M Jagosz, E Jędrzejczyk-Patej… - Kardiologia Polska …, 2022 - journals.viamedica.pl
… life-saving therapy for lethal ventricular arrhythmias. It has an … The optimal localization of the
S-ICD was assessed with the … (2.04%) had 1 VT with anti-tachycardia pacing therapy (ATP). …

ICD follow‐up and troubleshooting

KP Jackson - Cardiac Pacing and ICDs, 2020 - Wiley Online Library
… Arrhythmia termi nation by antitachycardia pacing (ATP) … statement on optimal implantable
cardioverterdefibrillator pro … inappropriate detection of ventricular tachycardia or fibrillation …

Devices for heart failure

PM Haydock - Medicine, 2022 - Elsevier
… be assessed for implantable cardioverterdefibrillator therapy … cases of sustained VT,
anti-tachycardia pacing can be used to … established on optimal heart failure medical therapy

Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta‐Analysis of Randomized Trials and Propensity Score–Matched …

KY Fong, CJR Ng, Y Wang, C Yeo… - Journal of the American …, 2022 - Am Heart Assoc
implantable cardioverterdefibrillator for patients requiring … or cardiac resynchronization or
antitachycardia pacing (ATP) is … the management of patients with ventricular arrhythmias and …

S-ICDs: advantages and opportunities for improvement

A Friedli, H Burri - Expert Review of Medical Devices, 2022 - Taylor & Francis
… /LAHRS consensus document on optimal ICD programming [… antitachycardia pacing (ATP)
and antibradycardia pacing. … implantable cardioverter-defibrillator to confirm appropriate …

[PDF][PDF] Non-invasive prediction of malignant ventricular arrhythmias and mortality in patients with implantable cardioverter-defibrillator

U Chaudhry - 2019 - portal.research.lu.se
… There is a shift of charge to positive, from -90 mV to +20 - 30 … optimisation, coronary
revascularisation and the use of … the ability to provide pacing, antitachycardia pacing (ATP) …

Are atrial high-rate episodes associated with increased risk of ventricular arrhythmias and mortality?

P Vergara, F Solimene, A D'Onofrio, EC Pisanò… - JACC: Clinical …, 2019 - jacc.org
… appropriately treated with 12,840 antitachycardia pacing … 2,435 patients with implantable
cardioverter-defibrillator (ICD… , antiarrhythmic therapy optimization and, when appropriate, non-…

Implantable Devices in Genetic Heart Disease: Disease-Specific Device Selection and Programming

S Hansom, Z Laksman - Cardiac Electrophysiology Clinics, 2023 - cardiacep.theclinics.com
… of the tachycardia into VF/polymorphic ventricular tachycardia, … VT, the benefit of antitachycardia
pacing (ATP) likely increases … statement on optimal implantable cardioverter-defibrillator

Electrical storm management in structural heart disease

V Dusi, F Angelini, C Gravinese, S Frea… - European Heart …, 2023 - academic.oup.com
… no anti-tachycardia pacing (ATP) therapies during capacitor … Implantable cardioverter
defibrillator interrogation and … effects and therefore of the optimal dose. However, preliminary …